Mental Health

Mental Health

Abstract

Introduction: Metabolic abnormalities, predominantly weight gain, are related with the use of Antipsychotic medications.

Objectives: This paper will help us understand the underlying factors that cause metabolic and cardiovascular abnormalities; and to advice interventions that would help improve the condition of mental health consumers.

Background: The review articles used in this paper shows a high linkage between metabolic and cardiovascular abnormalities with the use of Antipsychotic medications; which is one of the leading causes of mortality and morbidity among metal health consumers.

Approach: Selective Article Reviews are being used.

Findings and Implications: Metabolic and cardiovascular side effects such as weight gain, diabetes and hypertension are some of the risks of Antipsychotic drugs; however, there are other underlying factors that cause this such abnormalities such as genetic factors, lifestyle, and other medications. Hence, education, early monitoring and lifestyle modification is highly recommended.

Conclusion: Atypical drugs are the frequently used treatment for mental disorders, particularly schizophrenia; but despite of its metabolic and cardiovascular side effects still it’s used is increasing. Therefore, early intervention and monitoring must be implemented, with the promotions of education, lifestyle and diet management.

Introduction

It is well known that psychotropic drugs, in general and antipsychotic drugs, in particular have as one of their side effect liabilities and potential to cause weight gain and disturbances in metabolic parameters; and the prevalence of these risk is high among patients taking these drugs. At this point, it is still unclear why these drugs caused this such abnormalities and we don't know the way in which the potential to cause weight gain, hyperglycemia, hyperlipidemia relates to each other. This remains to be understood, however, with the use of...

Mental...